Is bacterial vaginosis a disease?
Bacterial vaginosis (BV) has been described as a disease, a disorder, a vaginal inflammation, an infection, a microbial dysbiosis, a condition, and in some women, a normal situation. In order to fit the definition of a disease, BV would have to be a disorder of function that produces specific signs or symptoms or affects the vagina in an aberrant way. Yet, there is little consistency in patients reporting signs and symptoms when BV is diagnosed, nor the appearance of aberrations to the vagina. If BV is not a disease, there are implications for its management and coverage of treatment costs, and for the conclusions drawn in a multitude of previous studies. It is time for BV to be redefined and for the various subsets to be given a separate terminology with specific methods of diagnosis and appropriate treatment and preventive strategies.
KeywordsBacterial vaginosis Disease Inflammation Microbiota Dysbiosis
Compliance with ethical standards
This article does not contain any original studies with human participants or animals performed by the author.
Conflict of interest
The author declares that he has no conflict of interest.
- Albert AY, Chaban B, Wagner EC, Schellenberg JJ, Links MG, van Schalkwyk J, Reid G, Hemmingsen SM, Hill JE, Money D, VOGUE Research Group (2015) A study of the vaginal microbiome in healthy Canadian women utilizing cpn60-based molecular profiling reveals distinct Gardnerella subgroup community state types. PLoS One 10(8):e0135620. https://doi.org/10.1371/journal.pone.0135620 CrossRefPubMedPubMedCentralGoogle Scholar
- Anonymous (accessed October, 2017). https://www.womenshealth.gov/a-z-topics/bacterial-vaginosis
- Borgdorff H, Gautam R, Armstrong SD, Xia D, Ndayisaba GF, van Teijlingen NH, Geijtenbeek TB, Wastling JM, van de Wijgert JH (2016) Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol 9(3):621–633. https://doi.org/10.1038/mi.2015.86 CrossRefPubMedGoogle Scholar
- Burton JP, Reid G (2002) Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis 186(12):1770–1780. https://doi.org/10.1086/345761 CrossRefPubMedGoogle Scholar
- Cauci S, Guaschino S, Driussi S, De Santo D, Lanzafame P, Quadrifoglio F (2002) Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 185(11):1614–1620. https://doi.org/10.1086/340417 CrossRefPubMedGoogle Scholar
- Centers for Disease Control (accessed October, 2017). https://www.cdc.gov/std/bv/stdfact-bacterial-vaginosis.htm
- Eschenbach DA (1989) Bacterial vaginosis: emphasis on upper genital tract complications. Obstet Gynecol Clin N Am 16(3):593–610Google Scholar
- Janulaitiene M, Paliulyte V, Grinceviciene S, Zakareviciene J, Vladisauskiene A, Marcinkute A, Pleckaityte M (2017) Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis. BMC Infect Dis 17(1):394. https://doi.org/10.1186/s12879-017-2501-y CrossRefPubMedPubMedCentralGoogle Scholar
- Jespers V, Kyongo J, Joseph S, Hardy L, Cools P, Crucitti T, Mwaura M, Ndayisaba G, Delany-Moretlwe S, Buyze J, Vanham G, van de Wijgert JHHM (2017) A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci Rep 7(1):11974. https://doi.org/10.1038/s41598-017-12198-6 CrossRefPubMedPubMedCentralGoogle Scholar
- Mayo Clinic (accessed October, 2017). http://www.mayoclinic.org/diseases-conditions/bacterial-vaginosis/symptoms-causes/syc-20352279
- McMillan A, Rulisa S, Sumarah M, Macklaim JM, Renaud J, Bisanz JE, Gloor GB, Reid G (2015) A multi-platform metabolomics approach identifies highly specific biomarkers of bacterial diversity in the vagina of pregnant and non-pregnant women. Sci Rep 5(1):14174. https://doi.org/10.1038/srep14174 CrossRefPubMedPubMedCentralGoogle Scholar
- Merriam-Webster (accessed October, 2017). https://www.merriam-webster.com/dictionary/food
- Pybus V, Onderdonk AB (1998) A commensal symbiosis between Prevotella bivia and Peptostreptococcus anaerobius involves amino acids: potential significance to the pathogenesis of bacterial vaginosis. FEMS Immunol Med Microbiol 22(4):317–327. https://doi.org/10.1111/j.1574-695X.1998.tb01221.x CrossRefPubMedGoogle Scholar
- Ravel J, Brotman RM, Gajer P, Ma B, Nandy M, Fadrosh DW, Sakamoto J, Koenig SS, Fu L, Zhou X, Hickey RJ, Schwebke JR, Forney LJ (2013) Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1(1):29. https://doi.org/10.1186/2049-2618-1-29 CrossRefPubMedPubMedCentralGoogle Scholar
- Senok AC, Verstraelen H, Temmerman M, Botta GA (2009) Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev 4:CD006289Google Scholar
- Skokovic-Sunjic D (2017) Clinical Guide to Probiotic Products. www.probioticchart.ca
- Stöppler MC (accessed October, 2017) http://www.medicinenet.com/bacterial_vaginosis_causes_symptoms_treatment/article.htm
- Swidsinski A, Mendling W, Loening-Baucke V (2005) Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106(5, Part 1):1013–1023. https://doi.org/10.1097/01.AOG.0000183594.45524.d2 CrossRefPubMedGoogle Scholar
- United Nations (accessed October, 2017). http://www.un.org/en/universal-declaration-human-rights/
- Widder S, Allen RJ, Pfeiffer T, Curtis TP, Wiuf C, Sloan WT, Cordero OX, Brown SP, Momeni B, Shou W, Kettle H, Flint HJ, Haas AF, Laroche B, Kreft JU, Rainey PB, Freilich S, Schuster S, Milferstedt K, van der Meer JR, Groβkopf T, Huisman J, Free A, Picioreanu C, Quince C, Klapper I, Labarthe S, Smets BF, Wang H, Isaac Newton Institute Fellows, Soyer OS (2016) Challenges in microbial ecology: building predictive understanding of community function and dynamics. ISME J 10(11):2557–2568CrossRefPubMedPubMedCentralGoogle Scholar
- Willis AT (1984) Anaerobic bacterial diseases now and then: where do we go from here? Rev Infect Dis 6(Suppl 1):S293–S299. https://doi.org/10.1093/clinids/6.Supplement_1.S293 CrossRefPubMedGoogle Scholar